NCT07881471Recruiting
Ideomotor Apraxia and Robotic Gait Rehabilitation Outcomes After Stroke
Effect of Ideomotor Apraxia on the Outcomes of Robotic Gait Rehabilitation in Patients With Stroke: A Prospective Observational Study
Source: ClinicalTrials.gov · Last updated 3 Nov 2026
Brief summary (registry, in English)
After a stroke, some people have difficulty planning and carrying out familiar movements. This difficulty is called ideomotor apraxia and cannot be explained by muscle weakness alone. It may influence how people improve during rehabilitation. This study will examine whether ideomotor apraxia is associated with changes in walking, balance, and independence in adults receiving rehabilitation after stroke at Izmir City Hospital. Participants will be assessed for apraxia before rehabilitation and followed during their usual rehabilitation program, which includes conventional rehabilitation and RehaWalk-supported gait training. Walking and other functional abilities will be evaluated before and after the rehabilitation program. Changes will be compared between participants with and without apraxia. The study will observe routine care. Participants will not be assigned to different treatments, and no experimental treatment will be provided. The findings may help clinicians understand whether apraxia is useful for predicting rehabilitation outcomes after stroke.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 60 (estimated)
- First submitted
- 12 Oct 2026
- Start date
- 30 Oct 2026
- Primary completion date
- 30 Sept 2027
- Lead sponsor
- Izmir City Hospital
- Diseases
- Stroke
- NCT number
- NCT07881471
What you commit to
- Study type: Observational
- Planned participants: 60
- From 30 Oct 2026 to the primary completion date, 30 Sept 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Orthopedic disease or previous surgery substantially affecting lower extremity function, including advanced osteoarthritis, lower extremity amputation, unhealed fracture, or severe contracture.
Other illness
- Failure to provide written informed consent or withdrawal of consent.
- Severe aphasia or advanced cognitive impairment preventing understanding or completion of the study assessments.
- Cerebellar stroke.
- Parkinson's disease, multiple sclerosis, motor neuron disease, or another neurological disorder that may affect walking.
- Cardiovascular or systemic disease preventing safe participation in robotic gait rehabilitation, including unstable angina, uncontrolled arrhythmia, decompensated heart failure, uncontrolled hypertension, acute infection, or severe respiratory failure.
- Conditions preventing safe use of the gait rehabilitation system, including inability to use the safety belt or suspension system appropriately, severe lower extremity deformity, serious skin lesions or pressure ulcers, or height or body weight outside the manufacturer's specified limits.
- Severe visual or hearing impairment preventing reliable administration of the assessments.
- Any condition judged by the investigator to make participation unsafe or prevent compliance with the study protocol.
Other
- Severe unilateral neglect.
- Severe plantar flexor spasticity, defined as a Modified Ashworth Scale score of 3 or higher.
Who the study is looking for
- Age 18 years or older.
- Clinically and radiologically confirmed ischemic or hemorrhagic stroke.
- Scheduled to receive robotic gait rehabilitation as part of routine clinical care.
- At least 1 month since stroke onset.
- Ability to walk at least 10 meters with or without an assistive device.
- Ability to stand independently or under supervision for at least 2 minutes.
- Brunnstrom lower extremity recovery stage of 3 or higher.
- Modified Ashworth Scale score below 3 for the plantar flexor muscle group.
- Sufficient upper extremity motor function to permit TULIA assessment, defined as a Fugl-Meyer Assessment upper extremity motor score of at least 20.
- Sufficient cognitive ability to understand the study assessments, defined as a Mini-Mental State Examination score of at least 18.
- Ability to understand the informed consent form and provide written informed consent.
Age in the registry: 18 years to 90 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Izmir City Hospital Coordinator of this site? Confirm its status | Izmir | Turkey (Türkiye) | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.